Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integrase inhibitor JTK-303 (GS 9137) that blocks strand transfer by the viral enzyme. It shares the core structure of quinolone antibiotics, exhibits an IC50 of 7.2 nM in the strand transfer assay, and shows an EC50 of 0.9 nM in an acute HIV-1 infection assay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the last 14 years, four more INSTIs were approved for treatment of HIV infection: elvitegravir, dolutegravir, bictegravir and cabotegravir147–150.”
From Structure and function of retroviral integrase (2022) · cites this paper as [147]
Citations
Cites
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy
Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H., & Johnston, D. (2004) · Science · doi:10.1126/science.1097065 · Cited by 449
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399
A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco
Blower, S. M., Gershengorn, H. B., & Grant, R. M. (2000) · Science · doi:10.1126/science.287.5453.650 · Cited by 390
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines
Gould, R. G., & Jacobs, W. A. (1939) · Journal of the American Chemical Society · doi:10.1021/ja01265a088 · Cited by 307
Research works printed but not linked: 4
- Barreca M. L., 2005, J. Med. Chem., 48, 7088
- Zhuang L., 2003, J. Med. Chem., 46, 456
- Anthony N. J., 2002, Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors. PCT Int. Appl. WO02/30930 A2
- Cecchetti V., 1996, J. Med. Chem., 39, 445
Cited by
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Retroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
The design of drugs for HIV and HCV
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2424 · Cited by 430
Shimura, K., Kodama, E., Sakagami, Y., Matsuzaki, Y., Watanabe, W., Yamataka, K., Watanabe, Y., Ohata, Y., Doi, S., Sato, M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01534-07 · Cited by 343
Self-citationNext generation organofluorine containing blockbuster drugs
Han, J., Remete, A. M., Dobson, L. S., Kiss, L., Izawa, K., Moriwaki, H., Soloshonok, V. A., & O’Hagan, D. (2020) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2020.109639 · Cited by 313
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
“Later-developed INSTIs, including elvitegravir (15) and S/GSK-1349572 (16), are in advanced clinical trials.”
BackgroundMalet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01228-07 · Cited by 283
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Hare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents
Millanao, A. R., Mora, A. Y., Villagra, N. A., Bucarey, S. A., & Hidalgo, A. A. (2021) · Molecules · doi:10.3390/molecules26237153 · Cited by 213
HIV drug resistance against strand transfer integrase inhibitors
Anstett, K., Brenner, B., Mesplede, T., & Wainberg, M. A. (2017) · Retrovirology · doi:10.1186/s12977-017-0360-7 · Cited by 176
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
McColl, D. J., & Chen, X. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.11.004 · Cited by 173
Goethals, O., Clayton, R., Van Ginderen, M., Vereycken, I., Wagemans, E., Geluykens, P., Dockx, K., Strijbos, R., Smits, V., Vos, A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00470-08 · Cited by 168
Pasquini, S., Mugnaini, C., Tintori, C., Botta, M., Trejos, A., Arvela, R. K., Larhed, M., Witvrouw, M., Michiels, M., Christ, F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003784 · Cited by 163
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
Serrao, E., Odde, S., Ramkumar, K., & Neamati, N. (2009) · Retrovirology · doi:10.1186/1742-4690-6-25 · Cited by 163
Transferable Mechanisms of Quinolone Resistance from 1998 Onward
Ruiz, J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-19 · Cited by 165
Massari, S., Daelemans, D., Barreca, M. L., Knezevich, A., Sabatini, S., Cecchetti, V., Marcello, A., Pannecouque, C. C., & Tabarrini, O. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901211d · Cited by 148
Quinoline and its Derivatives as Effective Corrosion Inhibitors for Mild Steel in Acidic Medium
Ebenso, E. E., Obot, I. B. B., & Murulana, L. C. (2010) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)15412-5 · Cited by 143
Alexpandi, R., Mesquita, J. F. D., Pandian, S. K., & Ravi, A. V. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01796 · Cited by 149
Marinello, J., Marchand, C., Mott, B. T., Bain, A., Thomas, C. J., & Pommier, Y. G. (2008) · Biochemistry · doi:10.1021/bi800791q · Cited by 142
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore
Deng, J. N., Sanchez, T. W., Al‐Mawsawi, L. Q., Dayam, R., Yunes, R. A., Garofalo, A., Bolger, M. B., & Neamati, N. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.041 · Cited by 132
Functional and structural characterization of the integrase from the prototype foamy virus
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn938 · Cited by 130
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Šenerović, L., Opsenica, D., Morić, I., Aleksić, I., Spasić, M., & Vasiljević, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_428 · Cited by 127
1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents
Li, Z., Zhan, P., & Liu, X. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711797655407 · Cited by 126
A historical sketch of the discovery and development of HIV-1 integrase inhibitors
Savarino, A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.12.1507 · Cited by 140
Roquebert, B., Damond, F., Collin, G., Matheron, S., Peytavin, G., Bénard, A., Campa, P., Chêne, G., Brun‐Vézinet, F., Descamps, D., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn335 · Cited by 131
Palladium-Catalyzed Tandem Amination Reaction for the Synthesis of 4-Quinolones
Zhao, T., & Xu, B. (2009) · Organic Letters · doi:10.1021/ol902626d · Cited by 123
Billamboz, M., Bailly, F., Barreca, M. L., Luca, L. D., Mouscadet, J. F., Calmels, C., Andréola, M., Witvrouw, M., Christ, F., Debyser, Z., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007085 · Cited by 132
Wakade, S. B., Tiwari, D. K., Ganesh, P. S. K. P., Phanindrudu, M., Likhar, P. R., & Tiwari, D. K. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b02429 · Cited by 117
Bosch, L., & Vilarrasa, J. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605095 · Cited by 124
Effect of HIV infection and antiretroviral therapy on immune cellular functions
Korencak, M., Byrne, M. E., Richter, E., Schultz, B. T., Juszczak, P., Ake, J. A., Ganesan, A., Okulicz, J. F., Robb, M. L., Reyes, B. D. L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126675 · Cited by 112
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
Smith, S. J., Zhao, X. Z., Passos, D. O., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13020205 · Cited by 130
Hadi, V., Koh, Y.-H., Sanchez, T. W., Barrios, D., Neamati, N., & Jung, K. W. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.057 · Cited by 110
Sato, M., Kawakami, H., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Matsuzaki, Y., Yamataka, K., Ikeda, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900460z · Cited by 109
Self-citationNonclassical Biological Activities of Quinolone Derivatives
Daneshtalab, M., & Ahmed, A. A. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3302n · Cited by 110
Summa, V., Petrocchi, A., Matassa, V. G., Gardelli, C., Muraglia, E., Rowley, M., Paz, O. G., Laufer, R., Monteagudo, E. S., & Pace, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060854f · Cited by 104
Inhibiting the HIV Integration Process: Past, Present, and the Future
Santo, R. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400674a · Cited by 112
HIV‐1 integrase inhibitors: 2005–2006 update
Dayam, R., Gundla, R., Al‐Mawsawi, L. Q., & Neamati, N. (2007) · Medicinal Research Reviews · doi:10.1002/med.20116 · Cited by 100
Elvitegravir: A New HIV Integrase Inhibitor
Shimura, K., & Kodama, E. N. (2009) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1397 · Cited by 101
Self-citationRetroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0024-2014 · Cited by 115
One-Pot Phosphine-Catalyzed Syntheses of Quinolines
Khong, S. N., & Kwon, O. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo3015825 · Cited by 94
German, P., Warren, D., West, S., Hui, J. H. P., & Kearney, B. P. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181eb376b · Cited by 92
Quinolone 3-Carboxylic Acid Pharmacophore: Design of Second Generation HIV-1 Integrase Inhibitors
Dayam, R., Al‐Mawsawi, L. Q., Zawahir, Z., Witvrouw, M., Debyser, Z., & Neamati, N. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070609b · Cited by 90
Low, A., Prada, N., Topper, M. B., Vaida, F., Castor, D., Mohri, H., Hazuda, D. J., Muesing, M. A., & Markowitz, M. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00397-09 · Cited by 101
Tiwari, D. K., Phanindrudu, M., Wakade, S. B., Nanubolu, J. B., & Tiwari, D. K. (2017) · Chemical Communications · doi:10.1039/c7cc01195d · Cited by 87
Baba, M., Miyake, H., Wang, X., Okamoto, M., & Takashima, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-06 · Cited by 86
Synthetic approaches to the 2013 new drugs
Ding, H. X., Leverett, C. A., Kyne, R. E., Liu, K. K. ‐., Fink, S. J., Flick, A. C., & O’Donnell, C. J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.056 · Cited by 93
Malet, I., Delelis, O., Soulié, C., Wirden, M., Tchertanov, L., Mottaz, P., Peytavin, G., Katlama, C., Mouscadet, J. F., Cálvez, V., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp014 · Cited by 87
HIV-1 Integrase Inhibitors: An Emerging Clinical Reality
Dayam, R., Al‐Mawsawi, L. Q., & Neamati, N. (2007) · Drugs in R&D · doi:10.2165/00126839-200708030-00003 · Cited by 83
Zhao, P., Yan, X., Yin, H., & Xi, C. (2014) · Organic Letters · doi:10.1021/ol500221u · Cited by 82
Chen, X., Tsiang, M., Yu, F., Hung, M., Jones, G. S., Zeynalzadegan, A., Qi, X., JIN, H., Kim, C. U., Swaminathan, S., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.054 · Cited by 90
Savarino, A. (2007) · Retrovirology · doi:10.1186/1742-4690-4-21 · Cited by 91
Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
Engelman, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006901 · Cited by 87
The role of the methoxy group in approved drugs
Chiodi, D., & Ishihara, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116364 · Cited by 85
Novel therapeutic strategies targeting HIV integrase
Quashie, P. K., Sloan, R. D., & Wainberg, M. A. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-34 · Cited by 85
Transition-Metal-Free Approach for the Synthesis of 4-Aryl-quinolines from Alkynes and Anilines
Phanindrudu, M., Wakade, S. B., Tiwari, D. K., Likhar, P. R., & Tiwari, D. K. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01204 · Cited by 74
Resistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, J. F., Delelis, O., Marcelin, A., & Tchertanov, L. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.001 · Cited by 81
HIV integrase inhibitors as therapeutic agents in AIDS
Nair, V., & Chi, G. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.539 · Cited by 72
Esposito, F., & Tramontano, E. (2014) · Antiviral Chemistry and Chemotherapy · doi:10.3851/imp2690 · Cited by 68
Métifiot, M., Maddali, K., Naumova, A., Zhang, X., Marchand, C., & Pommier, Y. G. (2010) · Biochemistry · doi:10.1021/bi100130f · Cited by 71
Eradication of HIV: current challenges and new directions
Marsden, M. D., & Zack, J. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn455 · Cited by 68
Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase
Ma, K., Wang, P., Fu, W., Wan, X., Zhou, L., Chu, Y., & Ye, D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.054 · Cited by 67
A Review on Quinoline Derived Scaffolds as Anti-HIV Agents
Chokkar, N., Kalra, S., Chauhan, M., & Kumar, R. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666181018163448 · Cited by 67
Viral enzymes containing magnesium: Metal binding as a successful strategy in drug design
Rogolino, D., Carcelli, M., Sechi, M., & Neamati, N. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.07.006 · Cited by 73
Goethals, O., Vos, A. M., Ginderen, M. V., Geluykens, P., Smits, V., Schols, D., Hertogs, K., & Clayton, R. (2010) · Virology · doi:10.1016/j.virol.2010.03.034 · Cited by 66
Serrao, E., Debnath, B., Otake, H., Kuang, Y., Christ, F., Debyser, Z., & Neamati, N. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301632e · Cited by 73
Investigating the Role of Metal Chelation in HIV-1 Integrase Strand Transfer Inhibitors
Bacchi, A., Carcelli, M., Compari, C., Fisicaro, E., Pala, N., Rispoli, G., Rogolino, D., Sanchez, T. W., Sechi, M., Sinisi, V., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200851g · Cited by 64
Structural Biology of HIV Integrase Strand Transfer Inhibitors
Jozwik, I. K., Passos, D. O., & Lyumkis, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.003 · Cited by 76
Structure−Activity Relationship Study on Anti-HIV 6-Desfluoroquinolones
Tabarrini, O., Massari, S., Daelemans, D., Stevens, M., Manfroni, G., Sabatini, S., Balzarini, J. M., Cecchetti, V., Pannecouque, C. C., & Fravolini, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701585h · Cited by 58
Hou, Y., McGuinness, D. E., Prongay, A. J., Feld, B., Ingravallo, P., Ogert, R. A., Lunn, C. A., & Howe, J. A. (2008) · SLAS Discovery · doi:10.1177/1087057108317060 · Cited by 56
Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
Zhao, X. Z., Smith, S. J., Maskell, D. P., Métifiot, M., Pye, V. E., Fesen, K., Marchand, C., Pommier, Y. G., Cherepanov, P., Hughes, S. H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00596 · Cited by 55
Bacchi, A., Biemmi, M., Carcelli, M., Carta, F., Compari, C., Fisicaro, E., Rogolino, D., Sechi, M., Sippel, M., Sotriffer, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800893q · Cited by 57
Sharma, V., Das, R., Mehta, D. K., Gupta, S., Venugopala, K. N., Mailavaram, R. P., Nair, A. B., Shakya, A. K., & Deb, P. K. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116674 · Cited by 57
New first and second generation inhibitors of human immunodeficiency virus-1 integrase
Pendri, A., Meanwell, N. A., Peese, K. M., & Walker, M. A. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.586631 · Cited by 60
Parella, R., & Babu, S. A. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b00582 · Cited by 54
Sanna, C., Scognamiglio, M., Fiorentino, A., Corona, A., Graziani, V., Caredda, A., Cortis, P., Montisci, M., Ceresola, E. R., Canducci, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195168 · Cited by 55
The use of 2-(1-alkoxyalkylidene)-1,3-dicarbonyl compounds in organic synthesis
Kudyakova, Y. S., Бажин, Д. Н., Goryaeva, M. V., Burgart, Y. V., & Салоутин, В. И. (2014) · Russian Chemical Reviews · doi:10.1070/rc2014v083n02abeh004388 · Cited by 53
Raltegravir: molecular basis of its mechanism of action
Mouscadet, J. F., & Tchertanov, L. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s3-5 · Cited by 70
Next-Generation Integrase Inhibitors: Where to After Raltegravir?
Karmon, S. L., & Markowitz, M. H. (2013) · Drugs · doi:10.1007/s40265-013-0015-5 · Cited by 58
HIV‐1 Integrase Inhibitors: Update and Perspectives
Семенова, Е. А., Marchand, C., & Pommier, Y. G. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56007-2 · Cited by 61
Santo, R. D., Costi, R., Roux, A., Miele, G., Crucitti, G. C., Iacovo, A., Rosi, F., Lavecchia, A., Marinelli, L., Giovanni, C. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001422 · Cited by 50
Anti-infectives Clinical progress of HIV-1 integrase inhibitors
Al‐Mawsawi, L. Q., Al-Safi, R. I., & Neamati, N. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.213 · Cited by 51
Development of integrase inhibitors for treatment of AIDS: An overview
Dubey, S., Satyanarayana, Y., & Lavania, H. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.01.024 · Cited by 49
Recent progress in antiretrovirals – lessons from resistance
Adamson, C. S., & Freed, E. O. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.02.003 · Cited by 50
Generation of ArS- and ArSe-Substituted 4-Quinolone Derivatives Using Sodium Iodide As an Inducer
Ghosh, P., Nandi, A. K., Chhetri, G., & Das, S. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01426 · Cited by 47
Quinolone derivatives: Potential anti‐HIV agent—development and application
Wang, R., Xu, K., & Shi, W. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900045 · Cited by 47
4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B
Zhi, Y., Gao, L., Jin, Y., Tang, C., Li, J.-Y., Li, J., & Long, Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.028 · Cited by 49
Liu, Y., Tian, Y., Su, K., Wang, P., Guo, X., & Chen, B. (2019) · Organic Chemistry Frontiers · doi:10.1039/c9qo01250h · Cited by 44
Targets for Inhibition of HIV Replication: Entry, Enzyme Action, Release and Maturation
Sierra, S., & Walter, H. (2012) · Intervirology · doi:10.1159/000331995 · Cited by 56
Sharma, H., Sanchez, T. W., Neamati, N., Detorio, M., Schinazi, R. F., Cheng, X., & Buolamwini, J. K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.009 · Cited by 42
HIV-1 IN Strand Transfer Chelating Inhibitors: A Focus on Metal Binding
Bacchi, A., Carcelli, M., Compari, C., Fisicaro, E., Pala, N., Rispoli, G., Rogolino, D., Sanchez, T. W., Sechi, M., & Neamati, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100343x · Cited by 42
Wakade, S. B., Tiwari, D. K., Phanindrudu, M., Pushpendra, & Tiwari, D. K. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.06.030 · Cited by 42
Wang, Z., & Vince, R. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.025 · Cited by 42
Fei, X., Zhou, Z., Li, W., Zhu, Y., & Shen, J. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201200172 · Cited by 41
Metadata
- Authors
- Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., Ikeda, S., Kodama, E., Matsuoka, M., & Shinkai, H.
- Affiliations
- Kyoto University (JP)
- Central Pharmaceutical Research Institute, JT Inc., 1-1 Murasaki-cho, Takatsuki, Osaka, 569-1125, Japan, and Institute for Virus Research, Kyoto University, 53 Shogoin Kawaramachi, Sakyo-ku, Kyoto, 606-8507, Japan
- Corresponding author
- Shinkai, Hisashi
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-02-15
- Volume
- 49
- Issue
- 5
- Pages
- 1506-1508
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025444624
- Cited by
- 328
- References
- 17
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 22 · 2018: 15 · 2017: 15 · 2016: 10 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 21
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase inhibitors, quinolones, strand transfer inhibition, antiretroviral drug design, HIV-1 replication, acute HIV-1 infection
- MeSH terms
- Anti-Bacterial Agents, Cell Line, DNA, Viral, Humans, Structure-Activity Relationship, Quinolones, HIV-1, HIV Integrase, HIV Integrase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.